# Inulin for Infections in the Intensive Care Unit

> **NCT03865706** · PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 94 (actual)

## Conditions studied

- Antibiotic Resistant Infection
- Nosocomial Infection
- Pathogen Transmission
- Nutrition Disorders
- Critical Illness
- Sepsis

## Interventions

- **DRUG:** Inulin Oral Suspension
- **DRUG:** Placebo Oral Suspension
- **DRUG:** Broad-spectrum antibiotics

## Key facts

- **NCT ID:** NCT03865706
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-14
- **Primary completion:** 2023-11-21
- **Final completion:** 2024-07-23
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03865706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03865706, "Inulin for Infections in the Intensive Care Unit". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03865706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*